Skip to main content

Overcoming resistance in ovarian cancer

Aug. 22, 2013, 8:00 AM

Ovarian cancer is most often diagnosed as aggressive, metastatic disease that is already resistant to standard platinum-based chemotherapy. The nuclear receptor TR3 has been implicated in mediating cancer cell death (apoptosis) in response to chemotherapeutic agents.

To identify possible roles for TR3 in ovarian cancer, Dineo Khabele, M.D., assistant professor of Obstetrics and Gynecology, and colleagues studied TR3 expression in a tissue microarray generated from ovarian tumor samples. The investigators found that low TR3 expression was associated with resistance to platinum chemotherapy and poorer overall survival. In cultured ovarian cancer cells, they showed that TR3 moved from the nucleus to the cytoplasm in cells that were sensitive to cisplatin, but not in resistant cells. Experimentally lowering the expression of TR3 reduced the effects of cisplatin on apoptosis and cell growth.

The findings, reported Aug. 1 in Cancer Research, suggest that disruption of TR3 activity contributes to platinum chemotherapy resistance in ovarian cancer. Increasing TR3 function may be a therapeutic strategy for overcoming this resistance.

This research was supported by grants from the National Institutes of Health (TR000445, CA068485, CA091408, RR024975, CA148887) and by the Marsha Rivkin Ovarian Cancer Foundation.

Recent Stories from VUMC News and Communications Publications

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Hope

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

Momentum

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

more